B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice

Journal of Immunotherapy

Volumn 28, Issue 5, 2005, Pages 461-466

  Cohen, Sharon ^a   Haimovich, Joseph ^a   Hollander, Nurit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

B cell lymphoma; Cell mediated immune responses; Idiotype vaccines; Plasma cell tumors

Indexed keywords

CD8 ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN IDIOTYPE; KEYHOLE LIMPET HEMOCYANIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; CANCER PREVENTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; IMMUNE RESPONSE; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

EID: 24144435943     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cji.0000171312.16171.77     Document Type: Article

References (30)

1. Daley MJ, Gebel HM, Lynch RG. Idiotype-specific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy. J Immunol. 1978;120:1620-1624.
2. George AJT, Folkard SG, Hamblin TJ, et al. Idiotype vaccination as a treatment for B cell lymphoma. J Immunol. 1988;141:2168-2174.
3. Campbell MJ, Esserman L, Levy R. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide. J Immunol. 1988;141:3227-3233.
4. Hsu FJ, Caspar CB, Czerwinski D, et al. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma. Long-term results of a clinical trial. Blood. 1997;88:3129-3135.
5. Bendandi M, Gocke CD, Kobrin CB, et al. Complete molecular remission induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nat Med. 1999;5:1171-1177.
6. Reichardt VL, Okada CY, Liso A, et al. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma: a feasibility study. Blood. 1999;93:2411-2419.
7. George AJT, Tutt AL, Stevenson FK. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1. J Immunol. 1987;138:628-634.
8. Syrengelas AD, Levy R. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection. J Immunol. 1999;162:4790-4795.
9. Cesco-Gaspere M, Benvenuti F, Burrone OR. BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies. Cancer Immunol Immunother. 2005;54:351-358.
10. Kwak L, Young HA, Pennington RW, et al. Vaccination with syngeneic lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci USA. 1996;93:10972-10977.
11. Levitsky HI, Montgomery J, Ahmazadeh M, et al. Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumor immunity. J Immunol. 1996;156:3858-3865.
12. Schultze JL, Nadler LM. T cell-mediated immunotherapy for B-cell lymphoma. J Mol Med. 1999;77:322-331.
13. Haimovich J, Kukulansky T, Weissman B, et al. Rejection of tumors of the B-cell lineage by idiotype-vaccinated mice. Cancer Immunol Immunother. 1999;47:330-336.
14. Bergman Y, Haimovich J. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur J Immunol. 1977;7:413-417.
15. Maloney DG, Kaminski MS, Burowski D, et al. Monoclonal anti-idiotype antibodies against the murine B-cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro. Hybridoma. 1985;4:191-209.
16. Lutz MB, Kukutsch N, Ogilvie ALJ, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223:77-92.
17. Heyfets A, Haimovich J, Hollander N. Determination of idiotype-specific T cells in idiotype-vaccinated mice. Immunol Lett. 2002;80:207-213.
18. Hakim I, Levy S, Levy R. A nine-amino acid peptide from IL-1β augments antitumor immune responses induced by protein and DNA vaccines. J Immunol. 1996;157:5503-5511.
19. King CA, Spellerberg MB, Zhu D, et al. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nat Med. 1998;4:1281-1286.
20. Singh G, Parker S, Hobart P. The development of a bicistronic DNA vaccine for B-cell lymphoma. Vaccine. 2002;20:1400-1411.
21. Campbell MJ, Esserman L, Byars NE, et al. Idiotype vaccination against murine B-cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol. 1990;145:1029-1036.
22. Flamand V, Sornasse T, Thielemans K, et al. Murine dendritic cells pulsed with tumor antigen induce tumor resistance in vivo. Eur J Immunol. 1994;24:606-610.
23. Hsu FJ, Benike C, Fagnoni F, et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med. 1996;2:52-58.
24. Timmerman JM, Levy R. Linkage of foreign carrier protein to a self-tumor antigen enhances the immunogenicity of a pulsed dendritic cell vaccine. J Immunol. 2000;164:4797-4803.
25. Osterborg A, Yi Q, Henriksson L, et al. Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. Blood. 1998;91:2459-2466.
26. + T cells. Blood. 2000;96:2828-2833.
27. + T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. Cell Immunol. 1993;148:177-188.
28. + T cells. Proc Natl Acad Sci USA. 2000;97:2697-2702.
29. Lim SH, Baily-Wood R. Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma. Int J Cancer. 1999;83:215-222.
30. Titzer S, Christensen O, Manzke O, et al. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. Br J Haematol. 2000;108:805-816.